AQR Capital Management
RNAM

AQR Capital Management’s Avidity Biosciences RNAM Stock Holding History

AQR Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,149
Closed -$1.02M – 3810
2025
Q4 		$1.02M Buy
+14,149
New +$914K ﹤0.01% 2543
2025
Q2 		– Sell
-10,785
Closed -$318K – 3380
2025
Q1 		$318K Sell
10,785
-2,276
-17% -$70.9K ﹤0.01% 2662
2024
Q4 		$380K Sell
13,061
-11,892
-48% -$497K ﹤0.01% 2391
2024
Q3 		$1.15M Buy
24,953
+12,911
+107% +$560K ﹤0.01% 1769
2024
Q2 		$492K Buy
+12,042
New +$346K ﹤0.01% 2062

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

AQR Capital Management's RNAM Position: Q1 2026 in Review

AQR Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 14,149 shares — an estimated $1.02M sold.

AQR Capital Management first reported a position in RNAM in Q2 2024 and held it in 5 quarters. The position peaked at $1.15M in Q3 2024. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • AQR Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • AQR Capital Management sold 14,149 Avidity Biosciences shares in Q1 2026, an estimated $1.02M.
  • AQR Capital Management first reported a position in Avidity Biosciences in Q2 2024 and held it in 5 quarters.
  • AQR Capital Management's Avidity Biosciences position peaked at $1.15M in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.